Interferon-α treatment of patients with hepatitis C: The role of a comprehensive risk-benefit assessment (multiple letters)

Muhamad Aly Rifai, Jennifer M. Loftis, Peter Hauser, Charles L. Raison, Marina Demetrashvili, Lucile Capuron, Andrew H. Miller

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Interferon-α treatment of patients with hepatitis C: The role of a comprehensive risk-benefit assessment (multiple letters)'. Together they form a unique fingerprint.